Obsidian Therapeutics Statistics
NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.20-0.02 (-0.15%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Obsidian Therapeutics by the numbers
Obsidian Therapeutics has a market capitalization of $815.4 million based on 61.77M shares outstanding. With trailing EPS of $-1.63, Obsidian Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.5% below its 50-day average and 29.4% below its 200-day average.
Average daily trading volume is 364.58K shares, or about $4.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OBX valuation vs. peer median
| Metric | OBX | Peer median | Difference |
|---|---|---|---|
| Market cap | $815.40M | $784.94M | +4% |
| Avg. volume | 364.58K | 2.34M | -84% |
Peer median across 8 companies: AVBP, IVA, ARDX, IMMX, LXRX, GERN, HELP, ANNX.
Valuation
- Market cap
- $815.40M
- EPS (TTM)
- $-1.63
- Shares outstanding
- 61.77M
Price and trading
- Previous close
- 13.22
- Open
- 13.02
- Day range
- 12.80 – 13.88
- 52-week range
- 12.16 – 49.97
- Beta
- —
- Volume
- 359.04K
- Average volume
- 364.58K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 815.40M
- Forward Pe
- -6.20
- Eps
- -1.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 49.97
- Week52 Low
- 12.16
- Avg Volume
- 364.58K
- Shares Outstanding
- 61.77M
- Ma50
- 18.72
- Ma200
- 18.70
- Pct From52w High
- -73.58%
- Pct From52w Low
- 8.55%